Valuation: Guard Therapeutics International AB

Market Cap 31.22M 3.24M 2.83M 2.62M 2.4M 4.55M 312M 4.63M 12.25M 152M 12.18M 11.91M 526M P/E 2024
-2.24x
P/E 2025 -0.24x
Enterprise Value -18.61M -1.93M -1.69M -1.56M -1.43M -2.71M -186M -2.76M -7.3M -90.88M -7.26M -7.1M -313M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
65.85%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Guard Therapeutics International AB

1 day+0.13%
1 week-2.52%
Current month-3.12%
1 month-2.52%
3 months+24.00%
6 months-24.02%
Current year+5.44%
1 week 1.4
Extreme 1.402
1.6
1 month 1.35
Extreme 1.35
1.8
Current year 0.88
Extreme 0.881
2.35
1 year 0.88
Extreme 0.881
27
3 years 0.88
Extreme 0.881
49.8
5 years 0.88
Extreme 0.881
112.5
10 years 0.88
Extreme 0.881
3,050
Manager TitleAgeSince
Chief Executive Officer 50 15/01/2019
Director of Finance/CFO 53 14/09/2020
Chief Tech/Sci/R&D Officer 66 01/01/2022
Director TitleAgeSince
Chairman 70 01/05/2021
Director/Board Member - 01/05/2024
Director/Board Member 63 29/05/2019
Date Insider Type Main position Quantity % Market Cap.
28/02/23Free 1,344,000 0.2672%
28/02/23Free

Chief Executive Officer

9,450,000 1.8784%
28/02/23Free 756,000 0.1503%
Change 5-day change 1-year change 3-year change Capi.($)
+0.13%-2.52%-91.73%-78.62% 3.24M
-0.17%+1.47%+3.16%+7.43% 50.35B
-0.18%-2.77%+387.98%+593.37% 39.32B
+0.16%+2.29%+32.20%-5.83% 34.69B
+1.19%+3.06%+15.35%+57.21% 34.08B
+1.68%-1.40%+4.23%+27.34% 26.63B
+0.08%-4.19% - - 16.49B
-0.44%+0.17%+70.41%+115.43% 15.31B
+0.43%+3.34%+14.96%+17.98% 13.8B
+0.63%+2.03%+15.97%-31.10% 12.87B
Average +0.35%-0.04%+50.28%+78.13% 24.35B
Weighted average by Cap. +0.33%-0.32%+82.18%+122.43%

Financials

2024 2025
Net sales - -
Net income -96.07M -9.98M -8.72M -8.05M -7.4M -14.02M -960M -14.26M -37.69M -469M -37.47M -36.65M -1.62B -109M -11.3M -9.88M -9.12M -8.38M -15.88M -1.09B -16.15M -42.71M -532M -42.45M -41.52M -1.83B
Net Debt -54.19M -5.63M -4.92M -4.54M -4.17M -7.91M -541M -8.04M -21.26M -265M -21.13M -20.67M -912M -49.83M -5.17M -4.52M -4.17M -3.84M -7.27M -498M -7.39M -19.55M -243M -19.43M -19.01M -839M
Logo Guard Therapeutics International AB
Guard Therapeutics International AB (publ), formerly A1M Pharma AB, is a Sweden-based company, which is active within the healthcare sector. The Company conducts development and commercialization of treatment and diagnostics based on the alpha-1-microglobulin (A1M) protein. The protein serves as a radical inhibitor, an antioxidant, a protector against free hemoglobin and a tissue repairer. A1M is a candidate for different therapeutic and diagnostic uses, such as alleviation of autoimmune diseases and stroke treatment. The Company works with the protein and conducts research at the Biomedical Center in Lund University, Sweden. The Company develops a drug for intravenous treatment of preeclampsia, a condition that can occur during pregnancy and can contribute to premature deliveries.
Employees
12
Date Price Change Volume
15/07/26 SEK 1.550 +0.13% 10,292
14/07/26 SEK 1.548 -1.90% 2,933
13/07/26 SEK 1.578 +1.15% 19,418
10/07/26 SEK 1.560 +11.27% 10,736
09/07/26 SEK 1.402 -11.82% 9,303

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GUARD Stock